Ibandronic acid
Recall
|
Medicines
|
18/04/2013
The marketing authorization holder informed its customers in a letter dated April 18, 2013, that due to a technical defect during production, isolated particles were observed in the prefilled syringes. In the course of a 100% inspection, prefilled syringes with particles were sorted out. Nevertheless, both batches CV2391 and CU9980 are recalled as a precautionary measure.
Name of the medicinal product | Ibandronsäure Sandoz 3 mg/3 ml - Injektionslösung |
---|---|
Marketing authorisation number(s) | 1-30134 |
Marketing authorisation holder | Sandoz GmbH, Kundl |
Batch number(s) | CV2391 und CU9980 |
Classification of the recall | 2 |
BASG reference number | INS-640.001-0725 |
Further inquiry note
Page last modified:
12/07/2022